Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression
Corrado Pelaia(Magna Graecia University), Nunzio Crimi(University of Catania), Maria D’Amato(Federico II University Hospital), Maria Filomena Caiaffa(University of Foggia), Girolamo Pelaia(Magna Graecia University), Giulia Scioscia(University of Foggia), Claudia Crimi(Marconi University), Cecilia Calabrese(University of Campania "Luigi Vanvitelli"), Santi Nolasco(University of Catania), Giuseppe Valenti(University of Palermo), Domenico Ciotta(University of Salerno), Giovanna Elisiana Carpagnano(University of Bari Aldo Moro), Alessandro Vatrella(University of Salerno), Alida Benfante(University of Palermo), Giuseppe Spadaro(University of Naples Federico II), Luigi Macchia(University of Bari Aldo Moro), Simona Pellegrino(University of Salerno), Nicola Scichilone
Cited by 61
Related Papers
A European survey of noninvasive ventilation practices
|European Respiratory Journal|2010|205
Determinants of tracheostomy decannulation: an international survey
|Critical Care|2008|177
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
|Arthritis & Rheumatology|2021|165
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
|Frontiers in Pharmacology|2022|157
Molecular Targets for Biological Therapies of Severe Asthma
|Frontiers in Immunology|2020|132